Mental health becomes new eldorado for pharmaceutical companies
Pharmaceutical companies are accelerating investments in mental health, a field considered highly profitable despite risks identified by major groups.
Published 13sem·2 sources✓ ConfirmedNotable
The fact
Depression, bipolar disorder, and schizophrenia represent major therapeutic targets for the global pharmaceutical industry.
This commercial strategy raises ethical issues about balancing therapeutic innovation with treatment dependency.
🔗2 sources — click a link to read an article on the topic:
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→Story timeline
Jun 22Mental health becomes new eldorado for pharmaceutical companiesthis article